Functional Nucleic Acid Molecule and Method - University of Edinburgh
Summary
The European Patent Office published patent application EP4284935A1 for the University of Edinburgh covering functional nucleic acid molecules and methods. Inventors include Steven Pollard, Ute Koeber, and Mantas Matjusaitis. The patent is classified under IPC C12N (biotechnology) and covers 38 designated contracting states.
What changed
The EPO published patent application EP4284935A1 for a functional nucleic acid molecule and associated methods, filed by the University Court of the University of Edinburgh. The application covers innovations in nucleic acid technology with inventors Steven Pollard, Ute Koeber, and Mantas Matjusaitis. Designated states include all major European Patent Convention member states.
For companies in biotechnology and pharmaceutical research, this patent publication establishes priority rights and provides notice of protected intellectual property. Organizations developing similar functional nucleic acid technologies should review freedom-to-operate implications and consider potential licensing discussions with the University of Edinburgh.
Source document (simplified)
FUNCTIONAL NUCLEIC ACID MOLECULE AND METHOD
Publication EP4284935A1 Kind: A1 Mar 25, 2026
Applicants
The University Court Of
The University of Edinburgh
Inventors
POLLARD, Steven, KOEBER, Ute, MATJUSAITIS, Mantas
IPC Classifications
C12N 15/85 20060101AFI20220805BHEP C12N 15/861 20060101ALI20220805BHEP C12N 15/10 20060101ALI20220805BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.